News ImmuCell Corporation

Stocks

ICCC

US4525253062

Pharmaceuticals

Delayed Nasdaq 13:15:57 2026-10-29 EDT			5-day change	1st Jan Change
10.54 ^USD	-0.72%		+0.99%	+71.43%

10-12	ImmuCell Q3 Preliminary Sales Rise	MT
10-12	Immucell Corporation Reports Preliminary Unaudited Sales Results for the Third Quarter and Nine Months Ended September 30, 2026	CI

All News

Mentions Relevance

10-12	ImmuCell Q3 Preliminary Sales Rise	MT
10-12	Immucell Corporation Reports Preliminary Unaudited Sales Results for the Third Quarter and Nine Months Ended September 30, 2026	CI
08-14	ImmuCell Corporation, Q2 2026 Earnings Call, Aug 14, 2026
08-13	ImmuCell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-13	ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026	AQ
08-06	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026	AQ
07-09	Immucell Corporation Reports Preliminary Unaudited Sales Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-09	ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results	AQ
05-15	ImmuCell Corporation, Q1 2026 Earnings Call, May 15, 2026
05-14	ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026	AQ
05-14	ImmuCell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-08	ImmuCell, Norbrook enter settlement deed on May 8, 2026 - SEC filing	RE
05-07	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026	AQ
04-22	ImmuCell : Corporate Presentation (Investor Relations April 2026 Final)	PU
04-13	ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors	AQ
04-13	ImmuCell Corporation Announces Board Changes	CI
04-08	ImmuCell Q1 Sales Jump; Shares Rise After Hours	MT
04-08	ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results	AQ
04-08	Immucell Corporation Announces Preliminary, Unaudited Sales Results for the Firs Quarter of 2026	CI
03-18	Immucell Corporation Announces Changes to Its Board, Effective April 1, 2026	CI
03-18	ImmuCell : 03-18-26 – ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board	PU
03-18	ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board	AQ
03-05	ImmuCell Corporation, Q4 2025 Earnings Call, Mar 05, 2026
03-04	ImmuCell Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
03-04	ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025	AQ